Sponsor:
AstraZeneca
Code:
NCT07590934
Conditions
Metastatic Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
AZD2265 (FPI-2265)
AZD9574
Docetaxel
AZD2287 (Imaging agent)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-04. This information was provided to ClinicalTrials.gov by AstraZeneca on 2026-06-30.